Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.00

+8.5%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Haynes who wrote (748)	3/3/2000 3:44:00 PM
From: Dave K	Read Replies (2) of 52153

>> Are biotechs now overvalued?<< Perhaps Drug Delivery become the next undiscovered wave to receive .Com - Bio slosh ....? <snip> "Neurogenomics will emerge as an important component of genomics, which will have an impact on the practice of neurology as diagnostics, drugs, and new drug delivery methods are integrated into patient care." "Both physicians and patients express strong drug loyalty in the management of epilepsy and are more likely to accept older drugs with improved profiles than new agents, thus there is ample opportunity for reformulated products with a benign side effect profile and/or higher effectiveness." messages.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next